Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Salestools Logo

Salestools

L'agent IA #1 pour les équipes de vente et Go-to-Market. Vendez plus, plus vite, avec moins d'effort.

Produit

  • Agents de vente IA
  • Données d'intention
  • Données technologiques
  • Suivi des visiteurs
  • Copilote
  • Vente sociale

Solutions

  • Service client
  • E-commerce
  • SaaS
  • Entreprise
  • Petite entreprise

Ressources

  • Le rapport
  • Documentation
  • Référence API
  • Centre d'aide
  • Blog
  • Études de cas
  • Webinaires

Entreprise

  • À propos
  • Carrières
  • Presse
  • Contact
  • Partenaires

Nos bureaux

  • New York, HQ
  • Bucarest, Laboratoire de recherche IA
  • Zug, Suisse

© 2025 Salestools. Tous droits réservés.

Conditions relatives aux données et sécuritéPolitique de confidentialitéConditions de service
Tous les systèmes opérationnels
Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Back to The Report
Fundraising

Generate Capital

Generate Capital Raises $1.5B in Growth

2014
Founded
400+
Employees
San Francisco, CA
Updated November 1, 2024
2 min read

Quick Facts

Generate Capital Raises $1.5B in Growth


Generate Capital has successfully raised $1.5B in a Growth at a $10B valuation led by AXA, QIA.


Company Overview


Generate Capital is a CleanTech company headquartered in San Francisco, CA, founded in 2014 with 400+ employees.


Sustainable infrastructure investing


Fundraising Details


  • Amount Raised: $1.5B
  • Round Type: Growth
  • Valuation: $10B
  • Date: 2024-11-01
  • Investors: AXA, QIA

About Generate Capital


Sustainable infrastructure investing The company is positioned in the CleanTech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: San Francisco, CA
  • Founded: 2014
  • Team Size: 400+
  • Industry: CleanTech

What This Means


This funding round demonstrates strong investor confidence in Generate Capital's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The CleanTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Generate Capital's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $10B valuation marks an important milestone for Generate Capital, positioning the company among notable players in the CleanTech industry.


Looking Ahead


With this new capital, Generate Capital is well-positioned to execute on its growth strategy and continue building innovative solutions in the CleanTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-11-01. For more information about Generate Capital, visit their headquarters at San Francisco, CA.

Topics

Fundraising(2912)CleanTechGrowthGenerate Capital

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million